...
首页> 外文期刊>Reviews in medical microbiology >Multidrug-resistant tuberculosis in Brazil: a snapshot from the National Reference Laboratory for Tuberculosis and other Mycobacterioses
【24h】

Multidrug-resistant tuberculosis in Brazil: a snapshot from the National Reference Laboratory for Tuberculosis and other Mycobacterioses

机译:巴西多药抗结核:来自国家参考实验室的结核病和其他分枝杆菌的快照

获取原文
获取原文并翻译 | 示例
           

摘要

Tuberculosis (TB) is a major public health concern worldwide. In 2015, there were approximately 10.4 million new cases of the disease, with 1.4 million deaths. Another major issue regarding TB is the worldwide emergence of drug-resistant strains. The National Reference Laboratory for Tuberculosis and other Mycobacterioses assists the entire network of the Tuberculosis Control Program in Brazil by performing complex diagnostic procedures for the entire country. Here we report the drug susceptibility testing activities of the laboratory between 2013 and 2015. Our numbers highlight the importance of vigilant control programmes to quickly detect, treat and eliminate drug-resistant TB cases, so as to avoid dissemination of drug-resistant forms of this important disease.
机译:结核病(TB)是全世界主要的公共卫生问题。 2015年,大约1040万疾病新病例,死亡140万。 关于TB的另一个主要问题是全球抗药性菌株的出现。 肺结核和其他药物的国家参考实验室通过对整个国家进行复杂的诊断程序,协助巴西结核病控制计划的整个网络。 在这里,我们在2013年和2015年之间报告了实验室的药物易感性测试活动。我们的号码突出了警惕控制方案快速检测,治疗和消除耐药性结核病病例的重要性,以避免传播这一抗药性形式 重要疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号